WHO ICTRP trial
A Study on the Safety and Efficacy of Sodium Phosphopentobarbital in Patients…
ChiCTR2500097793 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500097793 |
|---|---|
| Public title | A Study on the Safety and Efficacy of Sodium Phosphopentobarbital in Patients with Liver Cirrhosis for Painless Gastrointestinal Endoscopy |
| Scientific title | A Study on the Safety and Efficacy of Sodium Phosphopentobarbital in Patients with Liver Cirrhosis for Painless Gastrointestinal Endoscopy |
| Primary sponsor | Renmin Hospital of Wuhan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | liver cirrhosis |
| Interventions | Propofol Group:Propofol;Sodium Phosphopentobarbital Group:Sodium Phosphopentobarbital |
| Registration date | Feb 25, 2025 |
| Target size | Propofol Group:35;Sodium Phosphopentobarbital Group:35 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: